A number of studies have explored the role of visual, vestibular and somatosensory systems in the control of upright posture. However, the cortical control of postural stability, in general, and the role of higher cognitive function in assessment of postural stability, in specific, has been less studied. It is well established that certain features of postural control change during the advancing years of life so that the stability of posture can be a problem in the elderly. However, neural mechanisms of postural stability that decline with age and make older adults more prone to falling have not been identified specifically. To characterize specific causes of falling in the elderly in problematic, because human posture is a product of an extremely complex dynamical system and like any other physical activity undergoes dramatic changes in organization throughout the life-span. In our previous research we showed the existence of specialized neural detectors that are embodied in spatiotemporal patterns of brain activiation (Slobounov et al., 200) capable of discrimination the unstable postures in dynamic situations. We propose that these neural detectors may deteriorate with aging, which result in difficulty to (a) initiate compensatory postural adjustments when balance is in danger, and (b) to discriminate relevant from irrelevant information in control of upright posture. This can be documented via changes in behavioral correlates of postural control and spatiotemporal patterns of the brain activation as a function of advanced age. Accordingly, the purpose of this study is to investigate the age-related cortical control of postural stability combining electroencephalography and postural control measures. This will be done when a subject physically approaches the postural stability boundary and when a subject solves a cognitive task identifying unstable postures in dynamic situations.
INCLUSION CRITERIA: Subjects will be enrolled in this balance study if they are within the range of 20-90 years old; in good health; report no difficulties or need for help in performing self-care or instrumental activities of daily living; and are able to walk for at least 400 meters. EXCLUSION CRITERIA: We will be unable to study people who have substantial congitive impairment based on mental status screening tests; history of cardiovascular disease (including angina, myocardial infarction, congestive heart failure, cerebro-vascular disease); cancer; neurological diseases; birth defects; kidney or liver disease; gastrointestinal (G.I.) disease; musculo-skeletal disorder (if they cause pathological weakness and/or chronic pain); important sensory deficits and any conditions that precludes them from being tested with standard neurophyschological tests. Pregnant women will be excluded from this study. In addition, the following criteria are considered as markers of pathological conditions and are used as exclusion criteria for study enrollment: 1. HIV virus infection; 2. WBC greater than 12,000 ML; 3. Platelets less than 100,000 or greater than 600,000/ML; 4. Hemoglobin less than 11 gr/dl unless higher level can be ascribed to Gilbert's disease; 5. Abnormal level of SGOT and SGPT and alkaline phosphetase twice the norm serum concentration; 6. Corrected calcium less than 8.5 or 10.7 mg/dl; 7. Albumin less than 3.4 g/dl; 8. Shortness of breath while performing normal activities of daily living, such as walking or climbing stairs; 9. evidence or history of cancer; 10. absolute need for long term treatment with antibiotics, corticosteroids, immunosuppressors, H2 blockers and pain medications; 11. any severe psychiatric condition such as subjects with Axis I psychiatric diagnosis; 12. any condition that may preclude informed consent.